9vHPV Vaccine — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01-15 in 4mo
ESTIMATED |
READOUT
Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-v
Phase 3 · Papillomavirus Infections |
Merck Sharp & Dohme LLC | 9vHPV Vaccine |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-02
Sponsor-projected date — can change
|